IGF2 and cardiac hypertrophy: Pathological effect of HO-1-deficiency is additionally supported by, reported here, increased expression of IGF2-a key regulator of cardiac hypertrophy [50], which was followed by increased HO-1 KO hiPSC-CMs size.